Sarasota, FL, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Non-Invasive Prenatal Testing (NIPT) Market by Test Type (Panel 1, Panel 2 and Panel 3) and End-users (Hospitals, Diagnostic Centers, and Maternity Clinics): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2016 - 2022”. According to the report, global non-invasive prenatal testing (NIPT) market was valued at approximately USD 590.32 million in 2016 and is expected to generate revenue of around USD 1,086.36 million by end of 2022, growing at a CAGR of around 10.7% between 2017 and 2022.
Non-invasive prenatal testing is an advanced technology that helps determine fetal chromosomal anomalies by analyzing the fetus cell-free DNA. As the invasive procedures have a higher risk quotient, including the risk of fetal loss, most healthcare professionals prefer non-invasive techniques. NIPTs are new genetic tests that use cell-free circulating fetal DNA in the maternal serum to screen for more common fetal aneuploidies, such as trisomy 21, trisomy 18 (Edward syndrome), trisomy 13 (Patau syndrome), and monosomy X (Turner syndrome). With increased patient access to healthcare information as well as advertising, the NIPT market is anticipated to have a positive outlook in the coming years.
Browse through 61 Tables & 16 Figures spread over 110 Pages and in-depth TOC on "Global Non-Invasive Prenatal Testing Market by Type Size, Share, Growth and Forecast 2016 – 2022”.
Request Free Sample copy of Global Non-Invasive Prenatal Testing (NIPT) Market Report @ https://www.zionmarketresearch.com/sample/non-invasive-prenatal-testing-market
Advantages offered by NIPT such as non-invasiveness, high accuracy, and early detection, raising awareness, increasing market penetration in highly untapped countries in Asia and Latin America and continuous increase in average maternal age are the major factors expected to drive the growth of the global NIPT market during the forecast period. However, the market is also facing significant ethical and regulatory hurdles associated with the implementation of NIPT because of the belief that it is likely to increase the incidence of abortions. Therefore, various professional organizations such as the American College of Obstetricians and Gynecologists (ACOG), the International Society for Prenatal Diagnosis, the Japan Society of Obstetrics and Gynecology, and genetic counselors across the world have set up guidelines that limit the use of non-invasive prenatal testing only to pregnant women at high risk of chromosomal aneuploidies.
The non-invasive prenatal testing market is segmented on the basis of test type into panel 1, panel 2 and panel 3 test. Panel 1 segment is expected to grow at fastest rate in the global market over the forecast period. Hospitals, diagnostic centers, and maternity clinics are the key end-users of the global non-invasive prenatal testing market. The hospital's segment dominated the market in terms of revenue in 2016.
Browse the full " Non-Invasive Prenatal Testing (NIPT) Market by Test Type (Panel 1, Panel 2 and Panel 3) and End-users (Hospitals, Diagnostic Centers, and Maternity Clinics): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2016 - 2022" report at https://www.zionmarketresearch.com/report/non-invasive-prenatal-testing-market
North America dominated the global market in 2016, with the U.S. accounting for a major share of this regional market. Factors such as high incidence of chromosomal abnormalities, increasing maternal age, and increasing awareness programs are likely to drive the growth of the North American market.
Europe is the second largest regional market and is expected to show significant growth in the years to come. In Europe, NIPT is currently utilized primarily as a contingent screen, with NIPT offered to women with a serum screening determined risk over a certain threshold. Contingent NIPT proves to be cost saving in Europe making it a viable prenatal screening option.
Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/non-invasive-prenatal-testing-market
The Asian market is projected to grow at the highest CAGR during the forecast period owing to the increasing disposable income, rising awareness programs and conferences, and rising focus of market players to expand their presence in this region. Some prominent markets in Asia include China, India, and Japan.
In Middle East & Africa; African region is projected to register noticeable growth as several laboratories and companies have signed distribution agreements with test providers to be able to offer advanced products and services to patients, which is creating a positive impact in the region. Latin America is another important regional market and is expected to experience moderate growth over the forecast period. Thus, all the aforementioned parameters are expected to propel the market growth in this region.
Request customized copy of report @ https://www.zionmarketresearch.com/custom/2512
Some of the key players in the non-invasive prenatal testing market include Ariosa Diagnostics, Inc., Berry Genomics Co., Ltd, BGI Diagnostics, Illumina, Inc., LifeCodexx AG, Natera, Inc., Sequenom Laboratories, and Quest Diagnostics, Inc. The market is saturated with few players operating in the NIPT space and these companies are expected to compete on the grounds of cost and functionality. Product differentiation, new product launches and merger and acquisition are some of the strategies adopted by these industry participants.
For media inquiry contact our sales team @ sales@zionmarketresearch.com
This report segments the global non-invasive prenatal testing market as follows:
Global Non-Invasive Prenatal Testing (NIPT) Market: Test Type Segment Analysis
- Panel 1
- Panel 2
- Panel 3
Global Non-Invasive Prenatal Testing (NIPT) Market: End-user Segment Analysis
- Hospitals
- Diagnostic Centers
- Maternity Clinics
Global Non-Invasive Prenatal Testing (NIPT) Market: Regional Segment Analysis
- North America
- U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- The Middle East and Africa
Related Reports:
- Veterinary Anti-Infectives Market: https://www.zionmarketresearch.com/report/veterinary-anti-infectives-market
- Acromegaly Treatment Market: https://www.zionmarketresearch.com/report/acromegaly-treatment-market
- Generic Drug Market: https://www.zionmarketresearch.com/report/generic-drug-market
- Veterinary Vaccine Market: https://www.zionmarketresearch.com/report/veterinary-vaccine-market
- Active Pharmaceutical Ingredients market: https://www.zionmarketresearch.com/report/active-pharmaceutical-ingredients-market
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research